<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">12977</article-id><article-id pub-id-type="doi">10.7554/eLife.12977</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-47100"><name><surname>Abedini</surname><given-names>Andisheh</given-names></name><aff><institution content-type="dept">Diabetes Research Program, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine</institution>, <institution>New York University School of Medicine</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-47101"><name><surname>Plesner</surname><given-names>Annette</given-names></name><aff><institution>Novo Nordisk</institution>, <addr-line><named-content content-type="city">Bagsværd</named-content></addr-line>, <country>Denmark</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-47102"><name><surname>Cao</surname><given-names>Ping</given-names></name><aff><institution content-type="dept">Department of Chemistry</institution>, <institution>Stony Brook University</institution>, <addr-line><named-content content-type="city">Stony Brook</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-47103"><name><surname>Ridgway</surname><given-names>Zachary</given-names></name><aff><institution content-type="dept">Department of Chemistry</institution>, <institution>Stony Brook University</institution>, <addr-line><named-content content-type="city">Stony Brook</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-47104"><name><surname>Zhang</surname><given-names>Jinghua</given-names></name><aff><institution content-type="dept">Diabetes Research Program, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine</institution>, <institution>New York University School of Medicine</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-47105"><name><surname>Tu</surname><given-names>Ling-Hsien</given-names></name><aff><institution content-type="dept">Department of Chemistry</institution>, <institution>Stony Brook University</institution>, <addr-line><named-content content-type="city">Stony Brook</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-47106"><name><surname>Middleton</surname><given-names>Chris T</given-names></name><aff><institution>PhaseTech Spectroscopy, Inc.</institution>, <addr-line><named-content content-type="city">Madison</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-47107"><name><surname>Chao</surname><given-names>Brian</given-names></name><aff><institution content-type="dept">Diabetes Research Program, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine</institution>, <institution>New York University School of Medicine</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-47108"><name><surname>Sartori</surname><given-names>Daniel J</given-names></name><aff><institution content-type="dept">Diabetes Research Program, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine</institution>, <institution>New York University School of Medicine</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-47109"><name><surname>Meng</surname><given-names>Fanling</given-names></name><aff><institution content-type="dept">Department of Chemistry</institution>, <institution>Stony Brook University</institution>, <addr-line><named-content content-type="city">Stony Brook</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-47110"><name><surname>Wang</surname><given-names>Hui</given-names></name><aff><institution content-type="dept">Department of Chemistry</institution>, <institution>Stony Brook University</institution>, <addr-line><named-content content-type="city">Stony Brook</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-56569"><name><surname>Wong</surname><given-names>Amy G</given-names></name><aff><institution content-type="dept">Department of Chemistry</institution>, <institution>Stony Brook University</institution>, <addr-line><named-content content-type="city">Stony Brook</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-47111"><name><surname>Zanni</surname><given-names>Martin T</given-names></name><aff><institution content-type="dept">Department of Chemistry</institution>, <institution>University of Wisconsin-Madison</institution>, <addr-line><named-content content-type="city">Madison</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-47112"><name><surname>Verchere</surname><given-names>C Bruce</given-names></name><aff><institution content-type="dept">Child &amp; Family Research Institute and Department of Surgery and Pathology and Laboratory Medicine</institution>, <institution>University of British Columbia</institution>, <addr-line><named-content content-type="city">Vancouver</named-content></addr-line>, <country>Canada</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-27527"><name><surname>Raleigh</surname><given-names>Daniel P</given-names></name><aff><institution content-type="dept">Department of Chemistry</institution>, <institution>Stony Brook University</institution>, <addr-line><named-content content-type="city">Stony Brook</named-content></addr-line>, <country>United States</country><email>Daniel.Raleigh@stonybrook.edu</email></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-45248"><name><surname>Schmidt</surname><given-names>Ann Marie</given-names></name><aff><institution content-type="dept">Diabetes Research Program, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine</institution>, <institution>New York University School of Medicine</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country><email>annmarie.schmidt@nyumc.org</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1118"><name><surname>Kelly</surname><given-names>Jeffery W</given-names></name><role>Reviewing editor</role><aff><institution>The Scripps Research Institute</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>23</day><month>05</month><year>2016</year></pub-date><elocation-id>e12977</elocation-id><supplementary-material><ext-link xlink:href="elife-12977-supp-v2.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>12</day><month>11</month><year>2015</year></date><date date-type="accepted"><day>20</day><month>05</month><year>2016</year></date></history><permissions><copyright-statement>© 2016, Abedini et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Abedini et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Islet amyloidosis by IAPP contributes to pancreatic β-cell death in diabetes, but the nature of toxic IAPP species remains elusive. Using concurrent time-resolved biophysical and biological measurements, we define the toxic species produced during IAPP amyloid formation and link their properties to induction of rat INS-1 β-cell and murine islet toxicity. These globally flexible, low order oligomers upregulate pro-inflammatory markers and induce reactive oxygen species. They do not bind 1-anilnonaphthalene-8-sulphonic acid and lack extensive β-sheet structure. Aromatic interactions modulate, but are not required for toxicity. Not all IAPP oligomers are toxic; toxicity depends on their partially structured conformational states. Some anti-amyloid agents paradoxically prolong cytotoxicity by prolonging the lifetime of the toxic species. The data highlight the distinguishing properties of toxic IAPP oligomers and the common features that they share with toxic species reported for other amyloidogenic polypeptides, providing information for rational drug design to treat IAPP induced β-cell death.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd><kwd>Rat</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All procedures were approved by the Institutional Animal Care and Use Committee of New York University Langone Medical Center (NYULMC) and conform to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH) (8th Edition, 2011, ISBN 10: 0-309-15400-6). The Animal Care and Use Program at NYULMC are in full compliance with NIH policy (NYULMC Compliance Number is A3435-01).</p></fn></fn-group></back></article>